Clinical Trial Team to Send Interim Report of COVID-19 Vaccine in January's End

4 January 2021 17:53 WIB

Illustration of COVID-19 vaccine. REUTERS/Dado Ruvic

TEMPO.CO, JakartaThe COVID-19 vaccine clinical trial team planned to submit an interim report of the phase-3 trials of the vaccine candidates at the end of January 2021. The report will be the basis for the issuance of an emergency use authorization or EUA by the Food and Drug Monitoring Agency (BPOM).

“At the end of January, we will send an interim report to Bio Farma (pharmaceutical firm),” said clinical trial team head Kusnandi Rusmil in a webinar regarding the pandemic and global vaccines organized by the Padjadjaran University and the Indonesia Chamber of Commerce and Industry (Kadin) on Monday, January 4, 2021.

Indonesia is currently conducting the phase-3 clinical trials of the Sinovac vaccine produced in collaboration with Chinese pharmaceutical company Sinovac Biotech Ltd.

Since the clinical trials have not been completed, Kusnandi explained the effectiveness of the COVID-19 vaccine candidate remained unknown. However, he ensured that vaccination would not cause harmful effects.

He also believed that the vaccination program in Indonesia would run smoothly as the country had vast experience in conducting various types of immunization.

Read: Indonesia to Kick Off COVID-19 Vaccination Program Next Week

FRANCISCA CHRISTY ROSANA



BPOM Announces 172 Syrup Drugs Allowed Back in Circulation

16 jam lalu

BPOM Announces 172 Syrup Drugs Allowed Back in Circulation

The Indonesian Food and Drug Supervisory Agency (BPOM) continues to trace and follow up on the case of medicinal syrup contamination.


Jakarta Serves Second Booster Vaccination for Elderly Until December 31

8 hari lalu

Jakarta Serves Second Booster Vaccination for Elderly Until December 31

The second booster vaccine for the elderly is available in all vaccination services in the capital city.


Police Examine BPOM's Laboratory Head over Acute Kidney Injury Cases

8 hari lalu

Police Examine BPOM's Laboratory Head over Acute Kidney Injury Cases

The National Police's Criminal Investigation Unit (Bareskrim) question the BPOM's Laboratory Head over cases of acute kidney injury in children


Jakarta Starts Administering Second COVID-19 Booster for Elderly

9 hari lalu

Jakarta Starts Administering Second COVID-19 Booster for Elderly

The Jakarta government has started administering the second booster of COVID-19 shots for the elderly today, Nov. 23.


Jakarta Predicts November Will See Peak of COVID-19 Cases

9 hari lalu

Jakarta Predicts November Will See Peak of COVID-19 Cases

Jakarta Health Agency predicted that the peak of COVID-19 cases in the city will occur at the end of November 2022.


Indonesia Permits Second Boosters of Covid-19 for Elderly People

9 hari lalu

Indonesia Permits Second Boosters of Covid-19 for Elderly People

Taking into account the increasing number of Covid-19 cases, govt allows giving second boosters to elderly people.


Police Summon BPOM Head over Cases of Acute Kidney Injury in Children

11 hari lalu

Police Summon BPOM Head over Cases of Acute Kidney Injury in Children

The National Police summoned the head of the Food and Drug Monitoring Agency (BPOM) over cases of acute kidney injury in children.


Jakarta Aims to Intensify Polio Vaccination: Acting Governor

12 hari lalu

Jakarta Aims to Intensify Polio Vaccination: Acting Governor

Acting Governor of Jakarta Heru Budi Hartono stated that he would intensify polio vaccination in the capital city.


Acute Kidney Injury; BPOM Finds EG, DEG Contaminants 702 Times Safe Limit

14 hari lalu

Acute Kidney Injury; BPOM Finds EG, DEG Contaminants 702 Times Safe Limit

BPOM head Penny K Lukito reveals the investigation results on five pharmaceutical firms following the rising cases of acute kidney injury in children.


BPOM: 2 More Companies to Be Named Suspects in Acute Kidney Injury Cases

14 hari lalu

BPOM: 2 More Companies to Be Named Suspects in Acute Kidney Injury Cases

The Police's Bareskrim and BPOM name four companies as suspects in cases of acute kidney injury among children.